Arbutus Biopharma (ABUS) Q2 2023 Earnings

3AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.14
-0.13
-0.11
-0.1

Details

Expected EPS
-0.12
Actual EPS
-0.1
Surprise EPS
0.02
Surprise Percent
+16.67%

Description

Arbutus Biopharma (ABUS) has reported earnings of -0.1 per share for Q2 2023.

0 Comments

Share your thoughts